Vitamin E for NASH Treatment in HIV Infected Individuals
Status:
Recruiting
Trial end date:
2025-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see how taking Vitamin E daily affects fatty liver in persons
living with HIV. Subjects will have both HIV and a fatty liver and the purpose of the study
is to learn if underlying liver condition (fatty liver) gets better, worse, or stays the same
from taking Vitamin E.
Phase:
Phase 2
Details
Lead Sponsor:
Indiana University School of Medicine
Treatments:
alpha-Tocopherol Tocopherols Tocotrienols Vitamin E Vitamins